US: H Lundbeck A/S (HL), through its wholly owned Lundbeck Inc unit, has agreed to acquire all the outstanding stock of Ovation Pharmaceutical Inc (OP), a manufacturer of pharmaceuticals, from GTCR Golder Rauner LLC, for an estimated US$900m, including US$600m in cash and up to US$300m in profit-related payments.

More articles from Acquisitions Monthly
Japan's square Enix buys Eidos.(MOVING IN THE MID-MARKETS), March 01, 2009
G4S completes European exit.(MOVING IN THE MID-MARKETS), March 01, 2009
'Death of buyouts' much exaggerated: Javier Echarri, Secretary General..., March 01, 2009
Alliance Boots confident despite bleak outlook: executive chairman Ste..., March 01, 2009
Remaining relevant: Simon Walker, Chief Executive of the British Priva..., March 01, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.